Triple-Threat vaccine trial aims to shield seniors from three winter viruses

NCT ID NCT06604767

First seen Jan 31, 2026 · Last updated May 24, 2026 · Updated 16 times

Summary

This early-stage study tested whether a new combination vaccine is safe and helps the body build defenses against three respiratory viruses: RSV, hMPV, and PIV3. About 390 adults aged 60 and older received different doses or combinations of the vaccine. Researchers monitored side effects and measured antibody levels to see how well the vaccine worked.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational Site Number : 0360001

    Botany, New South Wales, 2019, Australia

  • Investigational Site Number : 0360002

    Camberwell, Victoria, 3124, Australia

  • Investigational Site Number : 0360003

    Bayswater, Victoria, 3153, Australia

  • Investigational Site Number : 0360004

    Miranda, New South Wales, 2228, Australia

  • Investigational Site Number : 0360005

    Kanwal, New South Wales, 2259, Australia

  • Investigational Site Number : 0360006

    Blacktown, New South Wales, 2148, Australia

  • Investigational Site Number : 0360008

    Herston, Queensland, 4006, Australia

  • Investigational Site Number : 0360009

    Brookvale, New South Wales, 2100, Australia

Conditions

Explore the condition pages connected to this study.